216 related articles for article (PubMed ID: 6176924)
21. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
22. High-risk metastatic gestational trophoblastic disease.
Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
[TBL] [Abstract][Full Text] [Related]
23. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
24. [Etoposide (VP-16) in gynecologic malignancy].
Kanazawa K; Moromizato H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1925-8. PubMed ID: 8978799
[TBL] [Abstract][Full Text] [Related]
25. [Chemotherapy of high-risk trophoblastic neoplasia].
Kawashima Y; Maeda M; Sugimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2658-66. PubMed ID: 2820310
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
27. Cerebral metastatic choriocarcinoma: intensive therapy and prognosis.
Weed JC; Hammond CB
Obstet Gynecol; 1980 Jan; 55(1):89-94. PubMed ID: 6243407
[TBL] [Abstract][Full Text] [Related]
28. [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Yang X; Han S
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):97-100. PubMed ID: 11263207
[TBL] [Abstract][Full Text] [Related]
29. Management of nonmetastatic trophoblastic tumors.
Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1981 Apr; 26(4):219-22. PubMed ID: 6260936
[No Abstract] [Full Text] [Related]
30. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
Goldstein DP; Berkowitz RS
Semin Oncol; 1982 Jun; 9(2):191-7. PubMed ID: 6289462
[No Abstract] [Full Text] [Related]
31. Management of high-risk gestational trophoblastic disease.
Lurain JR
J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
[TBL] [Abstract][Full Text] [Related]
32. Treatment of high-risk choriocarcinoma.
Bagshawe KD
J Reprod Med; 1984 Nov; 29(11):813-20. PubMed ID: 6097685
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for trophoblastic disease: current standards.
Kendall A; Gillmore R; Newlands E
Curr Opin Obstet Gynecol; 2002 Feb; 14(1):33-8. PubMed ID: 11801874
[TBL] [Abstract][Full Text] [Related]
34. Current management of low-risk metastatic gestational trophoblastic disease.
Jones WB
J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
[TBL] [Abstract][Full Text] [Related]
35. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Wan XR; Sun ZJ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
[TBL] [Abstract][Full Text] [Related]
36. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).
Bolis G; Bonazzi C; Landoni F; Mangili G; Vergadoro F; Zanaboni F; Mangioni C
Gynecol Oncol; 1988 Nov; 31(3):439-44. PubMed ID: 2846414
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
[TBL] [Abstract][Full Text] [Related]
38. [Gestational trophoblastic tumors and recent clinical information].
Shimizu T; Yaegashi N
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
[TBL] [Abstract][Full Text] [Related]
39. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of management of gestational trophoblastic tumor in National Taiwan University Hospital.
Ouyang PC
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1544-52. PubMed ID: 2543310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
